Aplisens SA (APN) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Aplisens SA PLN 31.31, price PLN 19.45, upside +61.0%, quality 64 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Aplisens SA for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range 8.75 PLN – 22.76 PLN · fair‑value band 21.66 PLN – 42.02 PLN · the 19.45 PLN price screens below the 31.31 PLN fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow Aplisens in your weekly email
Every Wednesday you see whether Aplisens is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Aplisens S.A. supplies industrial control and measurement equipment in Poland, European Union, CIS countries, the United States, Asia, and internationally.
Show more
Aplisens S.A. supplies industrial control and measurement equipment in Poland, European Union, CIS countries, the United States, Asia, and internationally. The company offers pressure, differential pressure, and level transducers; depth and level probes; electromagnetic flowmeters; measuring orifices; temperature sensors and transducers; valves and mounting accessories; meters, controllers, and displays; power supplies, separators, and signal transducers; fuel level probes for trucks; positioners; and electric actuators. It also provides consulting services related to the applications of its manufactured equipment; and warranty and post-warranty services. Its products are primarily focused on electronic pressure and differential pressure measurement technology. Aplisens S.A. was founded in 1992 and is headquartered in Warsaw, Poland.
Stock analysis
Aplisens SA (APN) currently trades at 19.45 PLN, while our model-based Fair Value estimate is 31.31 PLN, implying the stock looks roughly 37.9% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 32.33 PLN per share, and 17 of the 25 models we run sit above the 19.45 PLN price.
Bear case: the Dividend Discount group reads lowest at 7.10 PLN, and 8 of the 25 models stay below the price. Evidence for this calculation is high.
Scenario range: 21.66 PLN (bear) to 42.02 PLN (bull), the price of 19.45 PLN sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 64/100 (solid quality), in the Technology sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Aplisens SA reported revenue of 147M PLN in FY2025 versus 121M PLN in FY2021, a compound +4.8%/yr. Reported net income was 15.3M PLN in FY2025, compounding −3.0%/yr from FY2021.
Key figures
Market cap 211M PLN (≈ $54.9M) · P/E ratio 13.8 · P/S ratio 1.44 · EPS (TTM) 1.41 PLN · Dividend yield 4.6% · Net margin 10.4% · Return on equity 6.7% · Return on assets (EBIT) 12.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 7% below its 52-week high and 21% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Technology peers we cover trades at −35% fair-value upside, at 61%, APN screens cheaper than that median.
Fair Value models
Bear 21.66 PLNFair Value 31.31 PLNBull 42.02 PLN
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.3731 PLN per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.71/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−5.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.3%
Start year 2020 (pandemic). Over 10 years: +5.2% a year
Revenue growth 17 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.2%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+7.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+2.9%
Dividend (yield on the price)4.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.3% vs 3%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 13%
Start year 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−3.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Poland: IMF forecast 3.1% a year to 2030, 4.6% from 2016 to 2025) that is about −6.5% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Scientific & Technical Instruments · 160 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Aplisens SA Fair Value". https://www.fairvalue-calculator.com/stock/APN
Frequently asked questions
Is Aplisens SA (APN) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of 31.31 PLN versus a price of 19.45 PLN, about +61% upside (undervalued).
What is the fair value of APN?
Our model-based fair value for Aplisens SA is 31.31 PLN (as of Sep 23, 2026), built from audited fundamentals. The current price: 19.45 PLN.
What is the quality score of APN?
Aplisens SA has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Aplisens SA (APN)?
Our model-based price target is the fair value of 31.31 PLN (as of Sep 23, 2026) from 25 valuation models. Cautious scenario 21.66 PLN, optimistic scenario 42.02 PLN. It is a calculation from audited fundamentals, not an analyst target.
What is the Aplisens SA stock forecast for 2026?
Our models put fair value at 31.31 PLN, about +61% upside versus a price of 19.45 PLN (undervalued). Cautious scenario 21.66 PLN, optimistic scenario 42.02 PLN. The calculation is refreshed regularly with new filings.
What is the revenue of Aplisens SA (APN)?
Aplisens SA reported trailing-twelve-month revenue of about 147M PLN (latest available figure, as of Sep 23, 2026).
Does Aplisens SA pay a dividend?
Aplisens SA currently shows a dividend yield of about 4.63% relative to its recent price (as of Sep 23, 2026).
What growth is priced into Aplisens SA (APN)?
For today's price to be fair in a discounted-cash-flow model, Aplisens SA would have to grow free cash flow by -3.5 % per year for five years (discount rate 12.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +6.3 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of APN use?
Our models discount Aplisens SA at 12.1 %: a base by market capitalisation (micro), damped by beta 0.10, country premium for Poland. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Aplisens SA that is -3.5 % per year a year over ten years, using the same discount rate (12.1 %) and the same formula as our fair value.
How much growth has Aplisens SA (APN) delivered so far?
Over the past 5 years revenue at Aplisens SA grew +6.3 % a year. The price currently implies -3.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Aplisens SA (APN) growing?
The median revenue growth in the sector is +8.2 % a year. That is the yardstick for the growth priced into Aplisens SA (-3.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Aplisens SA (APN)?
The free-cash-flow yield on the price is 11.38 %: that much free cash flow Aplisens SA produces per unit of market value. When it exceeds the discount rate of our models (12.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Aplisens SA (APN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Aplisens SA it is 31.31 PLN per share (as of Sep 23, 2026), against a price of 19.45 PLN. It is the blended result of 25 valuation models (cash flow, earnings, asset, dividend).
Is Aplisens SA stock overvalued or undervalued in 2026?
As of Sep 23, 2026, APN trades below its calculated fair value: price 19.45 PLN, fair value 31.31 PLN, a gap of about +61% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of APN?
No. The price is what the market pays today (19.45 PLN); the fair value is what the company's own numbers justify (31.31 PLN). For Aplisens SA the two are 11.86 PLN per share apart. That gap is exactly why we show both numbers side by side.
How much is Aplisens SA worth?
The market values Aplisens SA at about 211M PLN (market capitalisation, as of Sep 23, 2026). Per share that is 19.45 PLN; our models calculate a fair value of 31.31 PLN per share.
What do the bullish and bearish scenarios say about APN?
Our models span a range for Aplisens SA: cautious scenario 21.66 PLN, base 31.31 PLN, optimistic 42.02 PLN per share (as of Sep 23, 2026, price 19.45 PLN). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of APN?
Aplisens SA trades at a price-to-earnings ratio of 13.8 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 31.31 PLN is built from several models across several years. Other multiples: P/B 0.2, P/S 0.4, EV/EBITDA 1.4.
How solid is the balance sheet of Aplisens SA (APN)?
Balance-sheet figures for Aplisens SA (as of Sep 23, 2026): return on equity 6.7%. They feed the Quality Score of 64/100, which measures business quality independently of the share price.
How far is APN from its 52-week high?
Aplisens SA trades at 19.45 PLN, about 7% below its 52-week high of 21.00 PLN and 21% above the low of 16.03 PLN (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 31.31 PLN is for.
Which stocks are comparable to Aplisens SA?
From the same area (Technology) we also value Keysight Technologies, Inc, Garmin Ltd, Teledyne Technologies Incorporated, Chroma ATE Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Aplisens SA stock attractive at the current price?
The data as of Sep 23, 2026: price 19.45 PLN, calculated fair value 31.31 PLN (+61%), Quality Score 64/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of APN calculated?
We run Aplisens SA through 25 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 31.31 PLN, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Aplisens SA currently trades 61 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Aplisens SA (APN)?
The closing price on Sep 23, 2026 was 19.45 PLN. Our model-based fair value is 31.31 PLN, about +61% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Aplisens SA right now?
The price is below even our cautious bear case (21.66 PLN). The market is more pessimistic than our downside scenario. Solid quality (64/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (21.66 PLN to 42.02 PLN) leaves room in how you read the outcome.
Where does the earnings growth of Aplisens SA (APN) come from?
Earnings per share at Aplisens SA grew +8.1 % a year from 2014 to 2025. Broken into its drivers: revenue per share +8.4 %, EBIT margin +0.0 %, tax rate −0.3 %, residual (interest, one-offs) +0.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Aplisens SA
How large is the market capitalisation of Aplisens SA (APN)?
The market capitalisation of Aplisens SA is 211M PLN (≈ $54.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Aplisens SA (APN)?
The price-to-sales ratio of Aplisens SA is 1.44 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Aplisens SA (APN)?
Earnings per share at Aplisens SA are 1.41 PLN (price ÷ EPS = P/E 13.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Aplisens SA (APN)?
The dividend yield of Aplisens SA is 4.6% (payout 63.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Aplisens SA (APN)?
The net margin of Aplisens SA is 10.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Aplisens SA (APN)?
The return on equity (ROE) of Aplisens SA is 6.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Aplisens SA (APN)?
On an EBIT basis the return on assets of Aplisens SA is 12.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Aplisens SA (APN)?
The operating margin of Aplisens SA is 13.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Aplisens SA (APN)?
Revenue at Aplisens SA is growing −0.1% versus a year earlier (3y avg −0.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Aplisens SA (APN)?
Earnings per share at Aplisens SA are growing −3.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Aplisens SA (APN) hold?
Aplisens SA holds more cash than debt, 14.6M PLN net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Aplisens SA in the live analysis
One click puts Aplisens SA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
